FDA Adverse Event Injury Summary report: N

MONOCRYL PLUS ANTIBACTERIAL SUTURE UNKNOWN PRODUCT

MDR report key: 7065167 · Received November 28, 2017

Report

Report Number
2210968-2017-71467
Event Type
Injury
Date Received
November 28, 2017
Report Date
November 2, 2017
Manufacturer
ETHICON INC.
Product Code
GAM
PMA / PMN Number
K050845
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). TO DATE THE DEVICE HAS NOT BEEN RETURNED. IF THE DEVICE OR FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ETHICON SUTURES CAUSED AND/OR CONTRIBUTED TO THE ADVERSE EVENTS DESCRIBED IN THE ARTICLE? IS THE PRODUCT CODE AND LOT NUMBER AVAILABLE FOR ANY OF THE ETHICON DEVICES USED? CITATION: EUR J CLIN MICROBIOL INFECT DIS 2015;34:2331-2338. DOI 10.1007/S10096-015-2485-8 -

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT # ==> PC-000057106 ADDITIONAL INFORMATION WAS REQUESTED AND THE FOLLOWING WAS OBTAINED: WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. NO DOES THE SURGEON BELIEVE THAT ETHICON PRODUCT MONOCRYL PLUS AND/ OR MONOCRYL, VICRYL OR VICRYL PLUS SUTURES CAUSED AND/OR CONTRIBUTED TO THE ADVERSE EVENTS DESCRIBED IN THE ARTICLE? NO IS THE PRODUCT CODE AND LOT NUMBER AVAILABLE FOR ANY OF THE ETHICON DEVICES USED? NO

Description of Event or Problem · 1

IT WAS REPORTED IN JOURNAL ARTICLE ¿TRICLOSAN-COATED SUTURES AND STERNAL WOUND INFECTIONS: A PROSPECTIVE RANDOMIZED CLINICAL TRIAL¿ THAT THE PURPOSE OF THIS PROSPECTIVE RANDOMIZED DOUBLE-BLIND SINGLE-CENTER STUDY WAS TO COMPARE THE RATE OF INFECTIONS IN STERNOTOMY WOUNDS CLOSED WITH TRICLOSAN-COATED OR CONVENTIONAL SUTURES. PATIENTS WERE RECRUITED BETWEEN MARCH 1, 2009 AND FEBRUARY 15, 2012. 357 PATIENTS WERE RANDOMIZED TO CLOSURE OF THE SURGICAL WOUNDS WITH EITHER TRICLOSAN-COATED SUTURES OR IDENTICAL SUTURES WITHOUT TRICLOSAN. IN THE TRICLOSAN GROUP (N=179; 41 WOMEN, 138 MEN; MEAN AGE 67.6+/-8.1 YEARS; MEAN BMI 27.7+/-4.1 KG/M2), TRICLOSAN-COATED WAS USED INTRACUTANEOUSLY. STERNAL WOUND INFECTION OCCURRED IN 12.8% (N=23: DEEP INFECTION, N=3; SUPERFICIAL INFECTION, N=20) IN THE TRICLOSAN GROUP. THERE WERE 16 (B)(6) CULTURES IN THE TRICLOSAN GROUP. THE MOST COMMON PATHOGENS IN BOTH GROUPS WERE (B)(6) AND COAGULASE-NEGATIVE STAPHYLOCOCCI. ANTIBIOTIC-TREATED STERNAL WOUND INFECTION WAS 13.4% (N=24) FOR BOTH GROUPS. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
843083 MONOCRYL PLUS ANTIBACTERIAL SUTURE UNKNOWN PRODUCT SUTURE, ABSORBABLE GAM ETHICON INC. UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention